NCT07121738 A Prospective Study of a Lifestyle Medicine Survivorship Program for Patients With Gynecologic Cancer
| NCT ID | NCT07121738 |
| Status | Recruiting |
| Phase | — |
| Sponsor | AdventHealth |
| Condition | Gynecologic Cancers |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2025-12-08 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2025-12-08 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will examine the effects of an 8-week intervention called the Healthy Eating Active Lifestyle (HEAL)-GYN program on participants' 1) self-efficacy 2) lifestyle factors, including physical activity and diet, as well as mental health and overall well-being, and 3) biometrics and biomarkers.
Eligibility Criteria
Inclusion Criteria: * Adult 18 years old or over * Diagnosis of gynecologic cancer * Current patient in the Central Florida area * Completing or have completed chemotherapy treatment within approximately the past 3 months before starting the program * Able to speak, read, and understand the English language. Exclusion Criteria: * Not willing or able to provide informed consent * Not willing or able to comply with all study procedures and requirement for the duration of the study
Contact & Investigator
Amanda T Sawyer, PhD
PRINCIPAL INVESTIGATOR
AdventHealth
Frequently Asked Questions
Who can join the NCT07121738 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Gynecologic Cancers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07121738 currently recruiting?
Yes, NCT07121738 is actively recruiting participants. Contact the research team at Amanda.Sawyer@AdventHealth.com for enrollment information.
Where is the NCT07121738 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT07121738 clinical trial?
NCT07121738 is sponsored by AdventHealth. The principal investigator is Amanda T Sawyer, PhD at AdventHealth. The trial plans to enroll 64 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.